158
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Expressions of Peptidoglycan Recognition Protein 1, Neuron Towards Axon Guidance Factor-1 and miR-142-3p and Their Correlations in Patients with Rheumatoid Arthritis

, , & ORCID Icon
Pages 3457-3464 | Received 09 May 2023, Accepted 20 Jul 2023, Published online: 15 Aug 2023

References

  • Akiyama M, Kaneko Y. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease. Autoimmun Rev. 2022;21(5):103056. doi:10.1016/j.autrev.2022.103056
  • Finckh A, Gilbert B, Hodkinson B, et al. Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. 2022;18(10):591–602. doi:10.1038/s41584-022-00827-y
  • Littlejohn EA, Monrad SU. Early diagnosis and treatment of rheumatoid arthritis. Prim Care. 2018;45(2):237–255. doi:10.1016/j.pop.2018.02.010
  • Sun J, Dai S, Zhang L, Feng Y, Yu X, Zhang Z. Investigating the safety and compliance of using csDMARDs in rheumatoid arthritis treatment through face-to-face interviews: a cross-sectional study in China. Clin Rheumatol. 2021;40:1789–1798. doi:10.1007/s10067-020-05458-w
  • Tan Y, Buch MH. “Difficult to treat” rheumatoid arthritis: current position and considerations for next steps. RMD Open. 2022;8(2):e002387. doi:10.1136/rmdopen-2022-002387
  • Li Y, Guo R, Oduro PK, et al. The relationship between porphyromonas gingivalis and rheumatoid arthritis: a meta-analysis. Front Cell Infect Microbiol. 2022;12:956417. doi:10.3389/fcimb.2022.956417
  • Sabi EM, Singh A, Althafar ZM, et al. Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis. Inflammopharmacology. 2022;30(3):737–748. doi:10.1007/s10787-022-00974-4
  • Gargano G, Oliva F, Oliviero A, Maffulli N. Small interfering RNAs in the management of human rheumatoid arthritis. Br Med Bull. 2022;142(1):34–43. doi:10.1093/bmb/ldac012
  • Ortiz F, Nylund KM, Ruokonen H, et al. Salivary biomarkers of oral inflammation are associated with cardiovascular events and death among kidney transplant patients. Transplant Proc. 2020;52(10):3231–3235. doi:10.1016/j.transproceed.2020.07.007
  • Ziegon L, Schlegel M. Netrin-1: a modulator of macrophage driven acute and chronic inflammation. Int J Mol Sci. 2021;23(1):275. doi:10.3390/ijms23010275
  • Yang J, Li Z, Wang L, et al. The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis. Pharmacol Res. 2022;186:106549. doi:10.1016/j.phrs.2022.106549
  • Chang C, Xu L, Zhang R, et al. MicroRNA-mediated epigenetic regulation of rheumatoid arthritis susceptibility and pathogenesis. Front Immunol. 2022;13:838884. doi:10.3389/fimmu.2022.838884
  • Li Y, Huang C, Yang Z, et al. Identification of potential biomarkers of gout through competitive endogenous RNA network analysis. Eur J Pharm Sci. 2022;173:106180. doi:10.1016/j.ejps.2022.106180
  • Mupparapu M, Oak S, Chang YC, Alavi A. Conventional and functional imaging in the evaluation of temporomandibular joint rheumatoid arthritis: a systematic review. Quintessence Int. 2019;50(9):742–753. doi:10.3290/j.qi.a43046
  • Takanashi S, Kaneko Y, Takeuchi T. CDAI and DAS28 in the management of rheumatoid arthritis in clinical practice. Ann Rheum Dis. 2020;79(5):671–674. doi:10.1136/annrheumdis-2019-216607
  • Rheumatology Branch of Chinese Medical Association. 2018中国类风湿关节炎诊疗指南 [2018 Chinese guideline for the diagnosis and treatment of rheumatoid arthritis]. Chin J Intern Med. 2018;57(4):242–251. Chinese. doi:10.3760/cma.j.issn.0578-1426.2018.04.004
  • Joint Surgery Branch of the Chinese Orthopaedic Association. 中国骨关节炎诊疗指南(2021年版) [Chinese guideline for diagnosis and treatment of osteoarthritis (2021 edition)]. Chin J Orthop. 2021;41(18):1291–1314. Chinese. doi:10.3760/cma.j.cn121113-20210624-00424
  • Sugihara T. Treatment strategies for elderly-onset rheumatoid arthritis in the new era. Mod Rheumatol. 2022;32(3):493–499. doi:10.1093/mr/roab087
  • Diesler R, Cottin V. Pulmonary fibrosis associated with rheumatoid arthritis: from pathophysiology to treatment strategies. Expert Rev Respir Med. 2022;16(5):541–553. doi:10.1080/17476348.2022.2089116
  • Yuan S, Li X, Lin A, Larsson SC. Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation. Semin Arthritis Rheum. 2022;53:151958. doi:10.1016/j.semarthrit.2022.151958
  • Mou X, Jin Y, Jin D, Guan J, Zhang Q. Serum HDAC4 level in rheumatoid arthritis: longitudinal change during treatment and correlation with clinical outcomes. J Clin Lab Anal. 2022;36(8):e24594. doi:10.1002/jcla.24594
  • Luo Q, Li X, Zhang L, et al. Serum PGLYRP-1 is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis. Mol Med Rep. 2019;19(1):589–594. doi:10.3892/mmr.2018.9632
  • Chen Y, Zhao B, Wu Y, et al. Impacts of diarrhea on the immune system, intestinal environment, and expression of PGRPs in New Zealand rabbits. PeerJ. 2017;5:e4100. doi:10.7717/peerj.4100
  • Sharma P, Yadav P, Jain RP, Bera AK, Karunagaran D. miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells. Life Sci. 2022;291:120268. doi:10.1016/j.lfs.2021.120268
  • Barnault R, Verzeroli C, Fournier C, et al. Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation. Hepatology. 2022;76(5):1345–1359. doi:10.1002/hep.32446
  • Mediero A, Wilder T, Ramkhelawon B, Moore KJ, Cronstein BN. Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis. FASEB J. 2016;30(11):3835–3844. doi:10.1096/fj.201600615R